Mark Sheptoff Financial Planning, LLC Bio N Tech Se Transaction History

Mark Sheptoff Financial Planning, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$123.25 - $186.24 $12,325 - $18,624	-100 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$205.93 - $447.23 $20,593 - $44,723	-100 Reduced 50.0%	100 $27,000
Q2 2021 Aug 12, 2021	BUY	$113.32 - $241.49 $22,664 - $48,298	200 New	200 $45,000
Q4 2020 Feb 11, 2021	SELL	$72.71 - $129.54 $36,355 - $64,769	-500 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$57.81 - $104.17 $28,905 - $52,085	500 New	500 $35,000

326

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.